Renuka Iyer Appointed New Chief Medical Officer of NCCN

The National Comprehensive Cancer Network has appointed Dr Renuka Iyer as its new Chief Medical Officer, marking a significant leadership transition for the organisation behind globally recognised cancer care guidelines. Dr Iyer brings more than two decades of academic and clinical experience, with a distinguished record in gastrointestinal oncology and research into rare cancers.

A Veteran Oncologist with Deep Clinical Expertise

Dr Iyer currently serves as Professor of Oncology at Roswell Park Comprehensive Cancer Center, where she also leads the Gastrointestinal Oncology section and oversees medical oncology across its care network. Her academic background includes training at Grant Medical College, residency at Cornell University, and an oncology fellowship at Roswell Park. She is board certified in internal medicine and oncology.

Contributions to Research and Professional Leadership

Her work spans immunotherapy, biomarkers, and quality-of-life research, with extensive publications and recognition from leading cancer organisations. Dr Iyer has been involved in guideline development through roles on professional panels, contributing to evidence-based practice across tumour types. Her leadership positions reflect a long-standing commitment to advancing cancer science and clinical standards.

Expanded Role in NCCN’s Guidelines and Education Mission

As CMO, Dr Iyer will guide the NCCN Guidelines programme, which includes 90 evidence-based clinical pathways updated frequently across cancer prevention, treatment, and supportive care. She will oversee point-of-care resources such as the NCCN Compendia, direct continuing education efforts, and participate in global and policy initiatives. Her responsibilities also extend to supporting the organisation’s journal and strategic framework.

Exam Oriented Facts

• Dr Renuka Iyer will assume the role of NCCN Chief Medical Officer on 26 February 2026.
• She is Section Chief of Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center.
• NCCN publishes 90 clinical practice guidelines updated at least annually.
• Dr Iyer has served on the NCCN Guidelines Steering Committee since 2023.

Strengthening NCCN’s Global Impact on Cancer Care

NCCN leadership highlighted Dr Iyer’s record in integrating innovation into clinical practice and her long-standing contributions to the organisation’s mission. Her appointment comes as NCCN expands its educational platforms and global collaborations, aiming to enhance equity, accessibility, and quality in cancer treatment worldwide.